CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
argenx SE Company Snapshot
argenx SE operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares argenx SE with three other miscellaneous service companies in Europe: Innate Pharma S.A. of FRANCE (2019 sales of 68.97 million Euros [US$81.43 million] of which 100% was conducting R&D on pharmaceutical produc), Oxford BioMedica plc of UNITED KINGDOM (£64.06 million [US$83.63 million] of which 80% was Platform), and MorphoSys AG which is based in GERMANY (71.76 million Euros [US$84.72 million] of which 52% was Partnered Discovery).

Sales Analysis. Sales increased substantially in 2019: argenx SE reported sales of 69.78 million Euro (US$82.39 million) for the year ending December of 2019. This represents an increase of 224.8% versus 2018, when the company's sales were 21.48 million Euro. Sales of Research and Development Service Fees (F saw an increase that was more than double the company's growth rate: sales were up 1,274.4% in 2019, from 1.41 million Euro to 19.34 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
argenx SE
  Stock Performance Chart for argenx SE
 
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 195.40
(Figures in Euros )
1 Week -10.9%   13 Weeks -7.1%  
4 Weeks 42.1%   52 Weeks 53.4%  
 
argenx SE Key Data:
  Ticker: ARGX Country: Netherlands
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 69,783,000
(Year Ending Jan 2020).
Employees: 188
  Currency: Euros Market Cap: 9,205,000,705
  Fiscal Yr Ends: December Shares Outstanding: 47,108,499
  Share Type: Actions Ordinaires Closely Held Shares: 280,941
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.